Skip to content

High-intensity Training Safely Improves Exercise Capacity in Heart, Lung, Kidney, and Liver Transplant Recipients: a Comparative Study

High-intensity Training Safely Improves Exercise Capacity in Heart, Lung, Kidney, and Liver Transplant Recipients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03329586
Enrollment
42
Registered
2017-11-06
Start date
2013-08-01
Completion date
2014-07-31
Last updated
2017-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity After Organ Transplantation

Keywords

maximum oxygen consumption, organ transplantation, physical fitness, rehabilitation

Brief summary

The investigators will investigate whether high-intensity exercise training can safely improve physical performance in long-term stable heart, kidney, lung, and liver transplant recipients. Adult transplant recipients will participate in Transplantoux, a 6-month individualized home- and group-based training program, with the goal to cycle the Mont Ventoux in France. The investigators will do cardiopulmonary exercise testing : maximal oxygen consumption, maximal power and BMI.

Interventions

6-month individualized home- and group-based training program with the goal to cycle the Mont Ventoux in France

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* minimum post-transplant period of 6 months * no acute rejection during the immediately preceding 6 months

Exclusion criteria

* patients with cardiovascular or orthopedic contra-indications for intensive physical exercise

Design outcomes

Primary

MeasureTime frameDescription
VO2max6 months after start trainingMaximal oxygen consumption

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026